VeriMommagnolia officinalis bark extract est-il sûr pendant la grossesse ?
No EU Annex II/III listing or harmonised CLP (H360/H361/H340/H350) was found for Magnolia officinalis bark extract; ECHA substance page lists the substance but does not show a harmonised reproductive/CMR classification. Animal/subchronic toxicity studies report effects at high oral doses but do not provide clear developmental/teratogenic evidence, and authoritative cosmetic safety bodies (CIR/SCCS) specific opinions were not found. Topical cosmetic exposure is expected to produce low but measurable systemic absorption for botanical extracts. (Sources: ECHA substance page; rat subchronic toxicity study; product/COSING listings; EWG summary).
Pregnancy-safe products containing magnolia officinalis bark extract
Related ingredients
Frequently asked questions
- magnolia officinalis bark extract est-il sûr pendant la grossesse ?
- No EU Annex II/III listing or harmonised CLP (H360/H361/H340/H350) was found for Magnolia officinalis bark extract; ECHA substance page lists the substance but does not show a harmonised reproductive/CMR classification. Animal/subchronic toxicity studies report effects at high oral doses but do not provide clear developmental/teratogenic evidence, and authoritative cosmetic safety bodies (CIR/SCCS) specific opinions were not found. Topical cosmetic exposure is expected to produce low but measurable systemic absorption for botanical extracts. (Sources: ECHA substance page; rat subchronic toxicity study; product/COSING listings; EWG summary).
- magnolia officinalis bark extract est-il sûr pendant l'allaitement ?
- No harmonised reproductive/breastfeeding hazard classification or EU cosmetic ban/restriction was identified. Human data on passage into breast milk are not available; animal studies at high oral doses show organ effects but do not document lactation-specific transfer. Topical use could result in low systemic exposure; therefore risk from topical cosmetic use is expected to be low but incompletely characterised. (Sources: ECHA; PubMed toxicity reviews; WebMD/CanABaby summaries).
- magnolia officinalis bark extract est-il sûr pour la peau de bébé ?
- Hazard and mechanism scores unchanged (no evidence of reproductive/developmental or endocrine-disrupting classification). Exposure score increased by +1 for infants because topical botanical extracts can be absorbed more on immature infant skin; therefore if adult topical exposure is low-measurable (1), infant exposure is moderate (2). No infant-specific dermal toxicity or developmental studies were located. (Sources: ECHA; infant-safety summaries; topical absorption rationale).
- Comment VeriMom évalue-t-il magnolia officinalis bark extract ?
- VeriMom évalue magnolia officinalis bark extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à magnolia officinalis bark extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à magnolia officinalis bark extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.